Implant Sciences Sells QS-B220 Explosives Trace Detectors for use at 19 Airports
- QS-B220 becomes the adopted standard for explosives trace detection equipment at a number of major airports in Latin American country
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 explosives trace detectors have been sold to a federal agency in charge of operating 19 airports in one Latin American country. The units will be used for checkpoint screening and air cargo screening.
"With this deployment, our QS-B220 has become the system of choice in explosives trace detection devices for these 19 airports. This is a major milestone for Implant Sciences and gives the Company a significant presence in the Latin American aviation security market," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The QS-B220 was selected based on its favorable total cost of ownership, superior performance capabilities, and its regulatory certifications."
Special Mission Aircraft Market - Global Forecast to 2020
Source : Implant Sciences Corporation
Mar 29 - 30, 2017 - London, United Kingdom